{
  "fidelity_criteria": [
    {
      "criterion": "Reward for accurately documenting the patient's admission that he sometimes forgets to take mesalamine because he gets caught up in work.",
      "weight": 20,
      "sense": "positive"
    },
    {
      "criterion": "Reward for recording the clinician\u2019s suggested adherence aids (phone reminders, pill organizer) exactly as discussed.",
      "weight": 15,
      "sense": "positive"
    },
    {
      "criterion": "Reward for capturing the patient\u2019s report that regular dosing improves symptoms whereas missed doses cause symptoms to return.",
      "weight": 15,
      "sense": "positive"
    },
    {
      "criterion": "Reward for including the clinician\u2019s instruction to notify the office promptly about any new symptoms or side-effects.",
      "weight": 10,
      "sense": "positive"
    },
    {
      "criterion": "Penalize for omitting or misrepresenting the current prescription of mesalamine 2.4 g daily or the active Crohn\u2019s disease diagnosis that are present in the chart.",
      "weight": 20,
      "sense": "negative"
    },
    {
      "criterion": "Penalize for documenting any medication change (dose adjustment, discontinuation, or new drug) that was not mentioned in the transcript.",
      "weight": 20,
      "sense": "negative"
    }
  ],
  "appropriateness_criteria": [
    {
      "criterion": "Reward for including a concrete, patient-centered plan to improve adherence (e.g., recommending a pill organizer and/or setting effective reminders).",
      "weight": 20,
      "sense": "positive"
    },
    {
      "criterion": "Reward for reinforcing evidence-based education that consistent mesalamine use is critical for Crohn\u2019s symptom control and relapse prevention.",
      "weight": 15,
      "sense": "positive"
    },
    {
      "criterion": "Reward for advising the patient to seek prompt medical attention if new symptoms or side-effects occur, thereby addressing patient safety.",
      "weight": 15,
      "sense": "positive"
    },
    {
      "criterion": "Penalize for failing to address the identified adherence barrier with any intervention or counseling in the plan.",
      "weight": 25,
      "sense": "negative"
    },
    {
      "criterion": "Penalize for unsafe or unjustified alteration of mesalamine therapy (dose change, stoppage) without clinical rationale.",
      "weight": 25,
      "sense": "negative"
    }
  ]
}